Argent BioPharma Statistics
Total Valuation
RGTLF has a market cap or net worth of 4.73 million. The enterprise value is 10.25 million.
Market Cap | 4.73M |
Enterprise Value | 10.25M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
Earnings Date | May 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +284.88% |
Shares Change (QoQ) | -0.50% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 14.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 25.85 |
PB Ratio | -0.70 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.73 |
EV / Sales | 54.23 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.48 |
Financial Position
The company has a current ratio of 0.16
Current Ratio | 0.16 |
Quick Ratio | 0.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -0.84 |
Interest Coverage | -422.13 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -121.60% |
Return on Invested Capital (ROIC) | -282.13% |
Return on Capital Employed (ROCE) | 195.82% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.03 |
Inventory Turnover | 0.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 0.83, so RGTLF's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | -66.67% |
50-Day Moving Average | 0.25 |
200-Day Moving Average | 3.67 |
Relative Strength Index (RSI) | 41.60 |
Average Volume (20 Days) | 73,081 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RGTLF had revenue of 183,076 and -14.00 million in losses. Loss per share was -0.28.
Revenue | 183,076 |
Gross Profit | -232,651 |
Operating Income | -12.28M |
Pretax Income | -14.00M |
Net Income | -14.00M |
EBITDA | -11.64M |
EBIT | -12.28M |
Loss Per Share | -0.28 |
Balance Sheet
The company has 444,574 in cash and 5.79 million in debt, giving a net cash position of -5.34 million.
Cash & Cash Equivalents | 444,574 |
Total Debt | 5.79M |
Net Cash | -5.34M |
Net Cash Per Share | n/a |
Equity (Book Value) | -6.73M |
Book Value Per Share | -0.12 |
Working Capital | -6.90M |
Cash Flow
In the last 12 months, operating cash flow was -6.83 million and capital expenditures -77,685, giving a free cash flow of -6.90 million.
Operating Cash Flow | -6.83M |
Capital Expenditures | -77,685 |
Free Cash Flow | -6.90M |
FCF Per Share | n/a |
Margins
Gross Margin | -127.08% |
Operating Margin | -6,705.91% |
Pretax Margin | -7,644.92% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RGTLF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -284.88% |
Shareholder Yield | -284.88% |
Earnings Yield | -295.75% |
FCF Yield | -145.90% |
Stock Splits
The last stock split was on October 30, 2023. It was a reverse split with a ratio of 0.001.
Last Split Date | Oct 30, 2023 |
Split Type | Reverse |
Split Ratio | 0.001 |
Scores
RGTLF has an Altman Z-Score of -89.9. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -89.9 |
Piotroski F-Score | n/a |